NCT00730678 Pharmacogenetic Determinants Of Treatment Response In Children
| NCT ID | NCT00730678 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Jude Children's Research Hospital |
| Condition | All Malignancies |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,800 participants |
| Start Date | 1998-08-17 |
| Primary Completion | 2033-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,800 participants in total. It began in 1998-08-17 with a primary completion date of 2033-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic traits by studying family members of individuals with specific genotypes.
Eligibility Criteria
Inclusion Criteria: * Any patients under evaluation/treatment at St. Jude Children's Research Hospital (SJCRH) * Parents or family members of St. Jude patients * Non patient volunteers * All study subjects must provide informed consent for participation * Assent/Consent of the patient (parent) must be provided prior to attempts made by investigators to enroll a family member of a SJCRH patient Exclusion Criteria:
Contact & Investigator
Jun J Yang, Ph. D.
PRINCIPAL INVESTIGATOR
St. Jude Children's Research Hospital
Frequently Asked Questions
Who can join the NCT00730678 clinical trial?
This trial is open to participants of all sexes, studying All Malignancies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00730678 currently recruiting?
Yes, NCT00730678 is actively recruiting participants. Contact the research team at referralinfo@stjude.org for enrollment information.
Where is the NCT00730678 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT00730678 clinical trial?
NCT00730678 is sponsored by St. Jude Children's Research Hospital. The principal investigator is Jun J Yang, Ph. D. at St. Jude Children's Research Hospital. The trial plans to enroll 8,800 participants.